Sirtris Pharmaceuticals, Inc. 4/A
4/A · Sirtris Pharmaceuticals, Inc. · Filed Jan 22, 2008
Insider Transaction Report
Form 4/AAmended
Elliott Peter
Senior VP, Head of Development
Transactions
- Award
Common Stock
2008-01-02+42,500→ 138,786 total - Award
Incentive Stock Option (Right to buy)
2008-01-02+42,500→ 42,500 totalExercise: $13.00Exp: 2018-01-02→ Common Stock (42,500 underlying)
Footnotes (1)
- [F1]The options shall vest as to 25% on January 2, 2009, with the remainder to vest in equal quarterly installments over the next 12 quarters ending April 2, July 2, and October 2 following January 2, 2009.